{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:30:33Z","timestamp":1788496233733,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX003928"],"award-info":[{"award-number":["I01BX003928"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK6BX005692"],"award-info":[{"award-number":["IK6BX005692"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ymthe.2025.10.010","type":"journal-article","created":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T02:35:11Z","timestamp":1759631711000},"page":"494-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["M2 macrophage exosomes reverse heart failure post-myocardial infarction by suppressing type 1 interferon signaling in myeloid cells"],"prefix":"10.1016","volume":"34","author":[{"given":"Martin","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex S.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuan Anh","family":"Phu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngan K.","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5442-3055","authenticated-orcid":false,"given":"Robert L.","family":"Raffai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.10.010_bib1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCULATIONAHA.114.012477","article-title":"Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease","volume":"131","author":"Navar-Boggan","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2025.10.010_bib2","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1161\/ATVBAHA.119.312578","article-title":"Myocardial Infarction-From Atherosclerosis to Thrombosis","volume":"39","author":"Palasubramaniam","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymthe.2025.10.010_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031745","article-title":"Acute Heart Failure Is a Malignant Process: But We Can Induce Remission","volume":"12","author":"Cotter","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ymthe.2025.10.010_bib4","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac Fibrosis: The Fibroblast Awakens","volume":"118","author":"Travers","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2025.10.010_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/FJC.0000000000000876","article-title":"The Role of Immune Cells in Cardiac Remodeling After Myocardial Infarction","volume":"76","author":"Zhang","year":"2020","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.10.010_bib6","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.ymthe.2018.04.024","article-title":"Exosomes in Myocardial Repair: Advances and Challenges in the Development of Next-Generation Therapeutics","volume":"26","author":"Adamiak","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.010_bib7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41577-018-0065-8","article-title":"Cardioimmunology: the immune system in cardiac homeostasis and disease","volume":"18","author":"Swirski","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.010_bib8","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1161\/ATVBAHA.114.304652","article-title":"Monocytes in myocardial infarction","volume":"35","author":"Dutta","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymthe.2025.10.010_bib9","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/nm.4428","article-title":"IRF3 and type I interferons fuel a fatal response to myocardial infarction","volume":"23","author":"King","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.10.010_bib10","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1161\/CIRCULATIONAHA.117.031046","article-title":"Cytosolic DNA Sensing Promotes Macrophage Transformation and Governs Myocardial Ischemic Injury","volume":"137","author":"Cao","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2025.10.010_bib11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.apsb.2021.05.011","article-title":"The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy","volume":"12","author":"Oduro","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ymthe.2025.10.010_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaz1974","article-title":"The myeloid type I interferon response to myocardial infarction begins in bone marrow and is regulated by Nrf2-activated macrophages","volume":"5","author":"Calcagno","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.010_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nature11260","article-title":"Myocardial infarction accelerates atherosclerosis","volume":"487","author":"Dutta","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.10.010_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120263","article-title":"Small molecule STING inhibition improves myocardial infarction remodeling","volume":"291","author":"Rech","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.ymthe.2025.10.010_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.10.010_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12345","article-title":"ApoE expression in macrophages communicates immunometabolic signaling that controls hyperlipidemia-driven hematopoiesis & inflammation via extracellular vesicles","volume":"12","author":"Phu","year":"2023","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymthe.2025.10.010_bib17","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.ymthe.2022.03.008","article-title":"IL-4 polarized human macrophage exosomes control cardiometabolic inflammation and diabetes in obesity","volume":"30","author":"Phu","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.10.010_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102847","article-title":"High glucose macrophage exosomes enhance atherosclerosis by driving cellular proliferation & hematopoiesis","volume":"24","author":"Bouchareychas","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.ymthe.2025.10.010_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107881","article-title":"Macrophage Exosomes Resolve Atherosclerosis by Regulating Hematopoiesis and Inflammation via MicroRNA Cargo","volume":"32","author":"Bouchareychas","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2025.10.010_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/FJC.0000000000000031","article-title":"The immunosuppressant FTY720 prolongs survival in a mouse model of diet-induced coronary atherosclerosis and myocardial infarction","volume":"63","author":"Wang","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.10.010_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/FJC.0000000000000312","article-title":"Immunosuppression With FTY720 Reverses Cardiac Dysfunction in Hypomorphic ApoE Mice Deficient in SR-BI Expression That Survive Myocardial Infarction Caused by Coronary Atherosclerosis","volume":"67","author":"Luk","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.10.010_bib22","doi-asserted-by":"crossref","first-page":"11064","DOI":"10.1074\/jbc.M111222200","article-title":"Hypomorphic apolipoprotein E mice: a new model of conditional gene repair to examine apolipoprotein E-mediated metabolism","volume":"277","author":"Raffai","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.10.010_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-4939-7652-2_7","article-title":"Cushioned-Density Gradient Ultracentrifugation (C-DGUC): A Refined and High Performance Method for the Isolation, Characterization, and Use of Exosomes","volume":"1740","author":"Li","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.10.010_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215324","article-title":"Cushioned-Density Gradient Ultracentrifugation (C-DGUC) improves the isolation efficiency of extracellular vesicles","volume":"14","author":"Duong","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.10.010_bib25","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41423-021-00668-x","article-title":"miR-23a\/b suppress cGAS-mediated innate and autoimmunity","volume":"18","author":"Yu","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.010_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034177","article-title":"A novel intracellular isoform of matrix metalloproteinase-2 induced by oxidative stress activates innate immunity","volume":"7","author":"Lovett","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.10.010_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/bs.pmbts.2017.02.001","article-title":"Matrix Metalloproteinases in Myocardial Infarction and Heart Failure","volume":"147","author":"DeLeon-Pennell","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.ymthe.2025.10.010_bib28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCRESAHA.112.266882","article-title":"Membrane-associated matrix proteolysis and heart failure","volume":"112","author":"Spinale","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2025.10.010_bib29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.1230719","article-title":"Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure","volume":"339","author":"Swirski","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.10.010_bib30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41590-018-0272-2","article-title":"Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction","volume":"20","author":"Dick","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.010_bib31","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41392-024-01840-1","article-title":"Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets","volume":"9","author":"Chen","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2025.10.010_bib32","doi-asserted-by":"crossref","first-page":"33811","DOI":"10.1074\/jbc.M111.270207","article-title":"Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2","volume":"286","author":"Piganis","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.10.010_bib33","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/ATVBAHA.115.305464","article-title":"Interferons as Essential Modulators of Atherosclerosis","volume":"35","author":"Boshuizen","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymthe.2025.10.010_bib34","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","article-title":"The Hippo signalling pathway and its implications in human health and diseases","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2025.10.010_bib35","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1186\/s12864-018-5213-9","article-title":"Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure","volume":"19","author":"Sweet","year":"2018","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ymthe.2025.10.010_bib36","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1093\/eurheartj\/ehab447","article-title":"The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms","volume":"42","author":"Baldini","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ymthe.2025.10.010_bib37","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/CIRCRESAHA.110.226928","article-title":"Multiple facets of NF-kappaB in the heart: to be or not to NF-kappaB","volume":"108","author":"Gordon","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2025.10.010_bib38","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41392-022-00972-6","article-title":"Signaling cascades in the failing heart and emerging therapeutic strategies","volume":"7","author":"He","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2025.10.010_bib39","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrrheum.2018.31","article-title":"Type I interferon in rheumatic diseases","volume":"14","author":"Muskardin","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ymthe.2025.10.010_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abe4627","article-title":"IFNAR1 and IFNAR2 play distinct roles in initiating type I interferon-induced JAK-STAT signaling and activating STATs","volume":"14","author":"Shemesh","year":"2021","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ymthe.2025.10.010_bib41","article-title":"Interferon Receptor Trafficking and Signaling: Journey to the Cross Roads","volume":"11","author":"Zanin","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.010_bib42","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0140-6736(12)60916-7","article-title":"Cardioprotection: chances and challenges of its translation to the clinic","volume":"381","author":"Heusch","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2025.10.010_bib43","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/eurheartj\/ehab068","article-title":"A call to action for new global approaches to cardiovascular disease drug solutions","volume":"42","author":"Figtree","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ymthe.2025.10.010_bib44","article-title":"cGAS-STING signaling in cardiovascular diseases","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.010_bib45","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s10557-023-07475-8","article-title":"SR-B1-\/-ApoE-R61h\/h Mice Mimic Human Coronary Heart Disease","volume":"38","author":"Starsichova","year":"2024","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ymthe.2025.10.010_bib46","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1073\/pnas.1525356113","article-title":"S1PR1-mediated IFNAR1 degradation modulates plasmacytoid dendritic cell interferon-alpha autoamplification","volume":"113","author":"Teijaro","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.10.010_bib47","article-title":"Occurrences and Functions of Ly6C(hi) and Ly6C(lo) Macrophages in Health and Disease","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.10.010_bib48","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.immuni.2016.02.017","article-title":"Yolk Sac Macrophages, Fetal Liver, and Adult Monocytes Can Colonize an Empty Niche and Develop into Functional Tissue-Resident Macrophages","volume":"44","author":"van de Laar","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2025.10.010_bib49","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nature06307","article-title":"Identification of Tim4 as a phosphatidylserine receptor","volume":"450","author":"Miyanishi","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.10.010_bib50","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.immuni.2021.07.003","article-title":"Resident cardiac macrophages mediate adaptive myocardial remodeling","volume":"54","author":"Wong","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2025.10.010_bib51","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.stemcr.2014.04.006","article-title":"Exosomes as critical agents of cardiac regeneration triggered by cell therapy","volume":"2","author":"Ibrahim","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.ymthe.2025.10.010_bib52","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIRCRESAHA.118.312420","article-title":"Exosomal microRNA-21-5p Mediates Mesenchymal Stem Cell Paracrine Effects on Human Cardiac Tissue Contractility","volume":"122","author":"Mayourian","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2025.10.010_bib53","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1161\/CIRCRESAHA.122.321384","article-title":"Intrapericardial Exosome Therapy Dampens Cardiac Injury via Activating Foxo3","volume":"131","author":"Zhu","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2025.10.010_bib54","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.10.010_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202200154","article-title":"A study of the THP-1 cell line as the potential biologics production platform with the emphasis on serum-free media substitution for economic expediency","volume":"17","author":"Kimiz-Gebologlu","year":"2022","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.ymthe.2025.10.010_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymthe.2025.10.010_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101384","article-title":"Protocol to induce and assess cGAS-STING pathway activation in vitro","volume":"3","author":"Chamma","year":"2022","journal-title":"STAR Protoc."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625008317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625008317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:31:52Z","timestamp":1783020712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625008317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1525001625008317"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.10.010","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.09.13.612924","asserted-by":"object"}]},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M2 macrophage exosomes reverse heart failure post-myocardial infarction by suppressing type 1 interferon signaling in myeloid cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}